19468030

Source:http://linkedlifedata.com/resource/pubmed/id/19468030

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0008976, umls-concept:C0013216, umls-concept:C0332293, umls-concept:C0439590, umls-concept:C0521425, umls-concept:C1274040, umls-concept:C1280500, umls-concept:C1512890, umls-concept:C1522577
pubmed:issue	8
pubmed:dateCreated	2009-8-5
pubmed:abstractText	The role of adjuvant dose-intensive chemotherapy and its efficacy according to baseline features has not yet been established.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA-75362
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-12087454, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-12514564, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-12598854, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-12840087, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-12840088, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-15111618, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-15208206, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-15265969, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-15767638, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-16135468, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-16325695, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-16421418, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-16446318, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-16505417, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-17172726, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-17675394, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-18043579, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-18174609, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-19117989, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-3316514, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-383274, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-3899355, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-6451282, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-831755, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-8874335, http://linkedlifedata.com/resource/pubmed/commentcorrection/19468030-9713266
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Filgrastim, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1569-8041
pubmed:author	pubmed-author:AebiSS, pubmed-author:BasserR LRL, pubmed-author:CinieriSS, pubmed-author:CoatesA SAS, pubmed-author:ColleoniMM, pubmed-author:GelberR DRD, pubmed-author:GoldhirschAA, pubmed-author:GreenM DMD, pubmed-author:International Breast Cancer Study Group, pubmed-author:MartinelliGG, pubmed-author:PeccatoriFF, pubmed-author:PriceK NKN, pubmed-author:SunZZ, pubmed-author:VialaCC
pubmed:issnType	Electronic
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1344-51
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19468030-Adult, pubmed-meshheading:19468030-Aged, pubmed-meshheading:19468030-Amenorrhea, pubmed-meshheading:19468030-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19468030-Breast Neoplasms, pubmed-meshheading:19468030-Cyclophosphamide, pubmed-meshheading:19468030-Disease-Free Survival, pubmed-meshheading:19468030-Dose-Response Relationship, Drug, pubmed-meshheading:19468030-Epirubicin, pubmed-meshheading:19468030-Female, pubmed-meshheading:19468030-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:19468030-Humans, pubmed-meshheading:19468030-Middle Aged, pubmed-meshheading:19468030-Neoplasms, Hormone-Dependent, pubmed-meshheading:19468030-Receptors, Estrogen, pubmed-meshheading:19468030-Recombinant Proteins, pubmed-meshheading:19468030-Stem Cell Transplantation, pubmed-meshheading:19468030-Survival Rate, pubmed-meshheading:19468030-Tamoxifen, pubmed-meshheading:19468030-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
pubmed:affiliation	Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy. marco.colleoni@ieo.it
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

More...